Charles River Laboratories International (CRL) Cash from Investing Activities (2009 - 2025)

Charles River Laboratories International's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$92.8 million for Q4 2025.

• In Q4 2025, Cash from Investing Activities fell 21.95% year-over-year to -$92.8 million; the TTM figure through Dec 2025 stood at -$209.3 million (up 14.59% YoY), while the FY2025 annual figure was -$209.3 million, up 14.59% from the prior year.
• Cash from Investing Activities for Q4 2025 stood at -$92.8 million, down from -$33.7 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $44.4 million in Q4 2022, with the low at -$954.2 million in Q2 2021.
• The 5-year median for Cash from Investing Activities is -$82.7 million (2023), against an average of -$153.2 million.
• The sharpest annual moves came in 2021 and 2022: Cash from Investing Activities plunged 3233.31% in 2021, then jumped 376.88% in 2022.
• Charles River Laboratories International's Cash from Investing Activities stood at $9.3 million in 2021, then surged by 376.88% to $44.4 million in 2022, then slumped by 637.08% to -$238.4 million in 2023, then surged by 68.07% to -$76.1 million in 2024, then retreated by 21.95% to -$92.8 million in 2025.
• Business Quant data shows CRL's Cash from Investing Activities at -$92.8 million in Q4 2025, -$33.7 million in Q3 2025, and -$37.3 million in Q2 2025.